After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
Researchers from Skoltech, prosthetics manufacturer Motorica, and Far Eastern Federal University have for the first time ...
Diabetes can damage your blood vessels over time because high blood sugar weakens their walls.
A neurosurgeon and a neuroscientist discover promising new ways to help people with spinal cord injuries walk again ...
BACKGROUND Guillain-Barre syndrome (GBS) commonly presents with motor weakness and neurological symptoms and signs that include loss of tendon reflexes. However, patients with GBS also experience ...
ALACHUA, Fla. and TAMPA, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, ...
The U.S. Food and Drug Administration (FDA) approved suzetrigine under the brand name Journavx on Jan. 30, 2025. Journavx is a first-in-class non-opioid painkiller that acts on sodium channels in the ...
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback